In leiomyosarcomas, increased tumor-associated macrophage (TAM) infiltration, identified using CD163 and CD68 markers, correlates with worse survival outcomes, particularly in non-gynecologic subtypes, suggesting its utility as a prognostic marker [28,30]. The gene discussed is CD163; the disease is neoplasm.